CARE Stock Overview
PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia.
Metro Healthcare Indonesia Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||Rp530.00|
|52 Week High||Rp605.00|
|52 Week Low||Rp318.00|
|1 Month Change||1.92%|
|3 Month Change||-5.36%|
|1 Year Change||63.58%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||281.29%|
Recent News & Updates
|CARE||ID Healthcare||ID Market|
Return vs Industry: CARE exceeded the ID Healthcare industry which returned 18.5% over the past year.
Return vs Market: CARE exceeded the ID Market which returned 18.3% over the past year.
|CARE Average Weekly Movement||4.3%|
|Healthcare Industry Average Movement||5.7%|
|Market Average Movement||6.2%|
|10% most volatile stocks in ID Market||12.0%|
|10% least volatile stocks in ID Market||2.9%|
Stable Share Price: CARE is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: CARE's weekly volatility (4%) has been stable over the past year.
About the Company
PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia. It owns and operates 7 hospitals. The company was founded in 2015 and is based in Tangerang, Indonesia.
Metro Healthcare Indonesia Fundamentals Summary
|CARE fundamental statistics|
Is CARE overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CARE income statement (TTM)|
|Cost of Revenue||Rp141.31b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.66|
|Net Profit Margin||7.58%|
How did CARE perform over the long term?See historical performance and comparison
Is Metro Healthcare Indonesia undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate CARE's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate CARE's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: CARE is poor value based on its Price-To-Earnings Ratio (802.5x) compared to the ID Healthcare industry average (20.1x).
PE vs Market: CARE is poor value based on its Price-To-Earnings Ratio (802.5x) compared to the ID market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CARE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CARE is overvalued based on its Price-To-Book Ratio (5.3x) compared to the ID Healthcare industry average (2x).
How is Metro Healthcare Indonesia forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Metro Healthcare Indonesia has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Metro Healthcare Indonesia performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CARE has a high level of non-cash earnings.
Growing Profit Margin: CARE's current net profit margins (7.6%) are higher than last year (4.4%).
Past Earnings Growth Analysis
Earnings Trend: CARE's earnings have grown significantly by 35.2% per year over the past 5 years.
Accelerating Growth: CARE's earnings growth over the past year (149.2%) exceeds its 5-year average (35.2% per year).
Earnings vs Industry: CARE earnings growth over the past year (149.2%) exceeded the Healthcare industry 121.6%.
Return on Equity
High ROE: CARE's Return on Equity (0.7%) is considered low.
How is Metro Healthcare Indonesia's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CARE's short term assets (IDR641.3B) exceed its short term liabilities (IDR73.4B).
Long Term Liabilities: CARE's short term assets (IDR641.3B) exceed its long term liabilities (IDR196.9B).
Debt to Equity History and Analysis
Debt Level: CARE has more cash than its total debt.
Reducing Debt: Insufficient data to determine if CARE's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CARE's debt is not well covered by operating cash flow (14.6%).
Interest Coverage: CARE earns more interest than it pays, so coverage of interest payments is not a concern.
What is Metro Healthcare Indonesia current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CARE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CARE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CARE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CARE's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CARE has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Henry Kembaren (63 yo)
Mr. Henry Kembaren, MM, is the President Director at PT Metro Healthcare Indonesia Tbk since 2019. He was Financial Analyst at PT Sehat Karunia Utama since 2016 until 2019; President Commissioner of PT Gad...
Experienced Management: CARE's management team is considered experienced (3.3 years average tenure).
Experienced Board: CARE's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PT Metro Healthcare Indonesia Tbk's employee growth, exchange listings and data sources
- Name: PT Metro Healthcare Indonesia Tbk
- Ticker: CARE
- Exchange: IDX
- Founded: 2015
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: Rp17.623t
- Shares outstanding: 33.25b
- Website: https://www.metrohealthcareindonesia.co.id
Number of Employees
- PT Metro Healthcare Indonesia Tbk
- Jl. Raya Serang Km 16,8
- RT/RW 005/001
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/28 00:00|
|End of Day Share Price||2022/05/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.